Cipla's arm completes first stage closing of Avenue Therapeutics

11 Feb 2019 Evaluate

Cipla's wholly owned subsidiary -- InvaGen Pharmaceuticals Inc., USA has completed the first stage closing of Avenue Therapeutics Inc., transaction representing an acquisition of 33.3% stake in Avenue's capital stock on fully diluted basis on February 08, 2019.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1466.15 5.55 (0.38%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×